Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 8:54 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2569–2592 of 17,766 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Population Clear all

Conditions: Crohn's Disease, Intestinal Fibrosis, Inflamatory Bowel Disease, Intestinal Strictures Related to Crohn´s Disease
Interventions: Ga68-FAPI-46; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Sickle Cell Disease
Interventions: iPeer2Peer Mentorship; Behavioral
Lead sponsor: The Hospital for Sick Children; Other
Eligibility: 12 Years to 18 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Dyslipidemia
Interventions: AZD0780, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 428 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 14
States / cities: Huntsville, Alabama • Lincoln, California • Palm Springs, California + 11 more

Conditions: Urinary Retention
Interventions: Tamsulosin 0.4Mg Capsule, Placebo oral tablet; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Weston, Florida

Conditions: Intestinal FDG Uptake
Interventions: Rifaximin; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Eosinophilic Asthma
Interventions: KT-621, Placebo; Drug · Other
Lead sponsor: Kymera Therapeutics, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 34
States / cities: Lancaster, California • Long Beach, California • Northridge, California + 28 more

Conditions: HIV/AIDS, Sexual Behavior, Woman's Role, Risk Behavior
Interventions: Love, Sex, & Choices video series, Messages in text; Other
Lead sponsor: Northeastern University; Other
Eligibility: 18 Years to 29 Years · Female only
Enrollment: 295 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Lung Transplant
Interventions: XPS™ with Steen Solution™; Device
Lead sponsor: XVIVO Perfusion; Industry
Eligibility: 18 Years and older
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2020
U.S. locations: 18
States / cities: Los Angeles, California • Aurora, Colorado • Gainesville, Florida + 15 more

Conditions: Type 1 Diabetes
Interventions: Mylan's insulin glargine, Lantus®; Drug
Lead sponsor: Mylan Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 558 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 72
States / cities: Bell Gardens, California • Fresno, California • Greenbrae, California + 64 more

Conditions: Diabetes Mellitus, Type 1
Interventions: Type One Training (TOT); Behavioral
Lead sponsor: Randi Streisand; Other
Eligibility: 21 Years to 99 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Low Back Pain
Interventions: T'ai Chi and Qigong Rehabilitation, Usual care; Other
Lead sponsor: New York Medical College; Other
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Valhalla, New York

Conditions: Healthy
Interventions: Early Childhood Friendship Project; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 4 Years to 6 Years
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Uterine Fibroids, Uterine Artery Embolization
Interventions: pregabalin/celecoxib, pregabalin/placebo, celecoxib/placebo, Placebo group; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Thermal Burns
Interventions: NexoBrid, Standard of Care (SOC), Gel Vehicle; Drug · Procedure
Lead sponsor: MediWound Ltd; Industry
Eligibility: 18 Years to 77 Years
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 18
States / cities: Mobile, Alabama • Phoenix, Arizona • Aurora, Colorado + 15 more

Conditions: Colon Cancer, Lung Cancer, Atrial Fibrillation, Diabetes Type 2, Obesity, Breast Cancer, Graves Disease, Osteoarthritis, Celiac Disease, Myocardial Infarction, Prostate Cancer
Interventions: SNP analysis; Genetic
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Alzheimer Disease
Interventions: Gantenerumab, Placebo; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 50 Years to 90 Years
Enrollment: 1,053 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 33
States / cities: Tucson, Arizona • Irvine, California • Sacramento, California + 29 more

Conditions: Patient Handoff
Interventions: Handoff Workshop; Other
Lead sponsor: George Washington University; Other
Eligibility: Not listed
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2012
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Pelvic Organ Prolapse (POP), Postoperative Pain, Urogynecology
Interventions: Suzetrigine, Placebo; Drug
Lead sponsor: Aditi Talkad; Other
Eligibility: 40 Years to 80 Years · Female only
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Failed Total Knee Arthroplasty
Interventions: Vitagel; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Obesity
Interventions: Goal-setting group, Control; Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 12 Years to 14 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Dementia
Interventions: Tailored Activity Program, Home Safety and Education Program; Behavioral · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years and older
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Surgical Abortion
Interventions: Doula Arm; Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older · Female only
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Generalized Anxiety Disorder
Interventions: SEP-363856, Placebo; Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 384 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 11
States / cities: Redlands, California • Orlando, Florida • Watertown, Massachusetts + 8 more

Conditions: Discrimination, Social, Health Care Utilization
Interventions: CBT Coping Intervention; Behavioral
Lead sponsor: RAND; Other
Eligibility: 18 Years and older · Male only
Enrollment: 369 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease

iPeer2Peer Program for Youth With Sickle Cell Disease

A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia

Preoperative Tamsulosin to Prevent Postoperative Urinary Retention After Surgery For Pelvic Floor Disorders

A Clinical Study to Limit Physiologic Intestinal FDG Uptake Uptake on PET-CT Scans

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

Reducing HIV Risk in Urban Women: Soap Opera Videos on Video-Capable Cell Phones

Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)

Healthy Eating, Physical Activity, and Glycemic Control in Young Children With T1D

Participating in T'ai Chi to Reduce Back Pain and Improve Quality of Life

The Early Childhood Friendship Project - Phase 3

Preemptive Analgesia Following Uterine Artery Embolization

A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns

Predictive Genetic Risk Assessment Trial

Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Effect of Hand-off Skills Training for Students During the Medicine Clerkship

Suzetrigine Following Urogynecologic Surgery: Investigation of Postoperative Pain Management

Vitagel Revision Total Knee Arthroplasty

The Use of Pedometers as an Adjunctive Tool in a School-based Pediatric Weight Management Program

Reducing Agitation in People With Dementia: the Customized Activity Trial

Patient Support During Surgical Abortion

A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder

Still Climbin': An Intervention to Improve Coping Among Black Sexual Minority Men